Diamond Hill Capital released its fourth-quarter 2025 investor letter, noting equity markets’ continued upward momentum led by IT and communication services sectors. The firm remains cautious of AI optimism, favoring stable, cash-generative businesses, and returned 1.41% in the quarter. Zoetis Inc. (NYSE:ZTS) saw a 3.41% return in the past month but underperformed in Q4 due to reduced 2026 outlook.

In its Q4 2025 investor letter, Diamond Hill Large Cap Fund highlighted Zoetis Inc. (NYSE:ZTS) as a leading relative detractor. The company focuses on animal health products, with its stock closing at $124.94 on February 2, 2026. Zoetis Inc. (NYSE:ZTS) has a market cap of $55.06 billion and delivered a 3.41% return in the past month.

Diamond Hill Large Cap Fund remains positive on Zoetis Inc. (NYSE:ZTS) long-term despite underperformance in Q4. The company cited fewer veterinary visits as reason for reduced 2026 outlook, but sees potential in its broad portfolio and strong pipeline for addressing pet conditions. Zoetis Inc. (NYSE:ZTS) is not among the 30 Most Popular Stocks Among Hedge Funds for 2024 Q3.

Read more at Yahoo Finance: Zoetis (ZTS) Traded Lower Due to Reduced 2026 Outlook